Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Outset Medical (Nasdaq: OM), a pioneering medical technology company focused on revolutionizing dialysis through cost and complexity reduction, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Chair & CEO Leslie Trigg will deliver a presentation on Wednesday, January 15, 2025, at 8:15 a.m. Pacific time.
Interested parties can access both live and archived versions of the presentation through the company's investor relations website at investors.outsetmedical.com.
Outset Medical (Nasdaq: OM), un'azienda tecnologica medica pionieristica che si concentra sulla rivoluzione della dialisi attraverso la riduzione dei costi e della complessità, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. Il Presidente e CEO Leslie Trigg presenterà un intervento mercoledì 15 gennaio 2025, alle 8:15 ora del Pacifico.
Le parti interessate possono accedere sia alle versioni in diretta che a quelle registrate della presentazione attraverso il sito web delle relazioni con gli investitori dell'azienda all'indirizzo investors.outsetmedical.com.
Outset Medical (Nasdaq: OM), una empresa pionera en tecnología médica enfocada en revolucionar la diálisis a través de la reducción de costos y complejidad, ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan Healthcare. La Presidenta y CEO Leslie Trigg realizará una presentación el miércoles 15 de enero de 2025, a las 8:15 a.m. hora del Pacífico.
Las partes interesadas pueden acceder tanto a las versiones en vivo como a las grabadas de la presentación a través del sitio web de relaciones con los inversores de la empresa en investors.outsetmedical.com.
Outset Medical (Nasdaq: OM), 비용 절감과 복잡성 감소를 통해 투석을 혁신하는 데 중점을 둔 혁신적인 의료 기술 회사는 제43회 연례 J.P. Morgan Healthcare 컨퍼런스에 참여한다고 발표했습니다. 회장 겸 CEO Leslie Trigg가 2025년 1월 15일 수요일 태평양 표준시 오전 8시 15분에 발표를 진행할 예정입니다.
관심 있는 분들은 회사의 투자자 관계 웹사이트인 investors.outsetmedical.com을 통해 라이브 및 녹화된 발표 버전을 모두 접속할 수 있습니다.
Outset Medical (Nasdaq: OM), une entreprise pionnière dans le domaine de la technologie médicale qui se concentre sur la révolution de la dialyse par la réduction des coûts et de la complexité, a annoncé sa participation à la 43ème Conférence Annuelle J.P. Morgan Healthcare. La Présidente et CEO Leslie Trigg fera une présentation le mercredi 15 janvier 2025, à 8h15 heure du Pacifique.
Les parties intéressées peuvent accéder aux versions en direct et archivées de la présentation via le site web des relations avec les investisseurs de l'entreprise à l'adresse investors.outsetmedical.com.
Outset Medical (Nasdaq: OM), ein wegweisendes Medizintechnikunternehmen, das sich darauf fokussiert, die Dialyse durch Kosten- und Komplexitätsreduktion zu revolutionieren, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. Vorsitzende und CEO Leslie Trigg wird eine Präsentation am Mittwoch, den 15. Januar 2025, um 8:15 Uhr Pazifischer Zeit halten.
Interessierte Parteien können sowohl auf Live- als auch auf archivierte Versionen der Präsentation über die Webseite für Investorenbeziehungen des Unternehmens unter investors.outsetmedical.com zugreifen.
- None.
- None.
SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 43rd annual J.P. Morgan Healthcare conference on Wednesday, January 15, 2025, at 8:15 a.m. Pacific time.
A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
Contact
Jim Mazzola
Vice President, Investor Relations
jmazzola@outsetmedical.com
FAQ
When is Outset Medical (OM) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Outset Medical's J.P. Morgan Healthcare Conference presentation?
What is the focus of Outset Medical's (OM) technology presentation at JPM 2025?
Who will represent Outset Medical (OM) at the 2025 J.P. Morgan Healthcare Conference?
